Nisa Investment Advisors LLC Buys 1,363 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Nisa Investment Advisors LLC boosted its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 80.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,066 shares of the company’s stock after buying an additional 1,363 shares during the quarter. Nisa Investment Advisors LLC’s holdings in Option Care Health were worth $107,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Murphy & Mullick Capital Management Corp purchased a new position in Option Care Health in the 4th quarter worth approximately $26,000. Signaturefd LLC raised its position in shares of Option Care Health by 487.9% during the 4th quarter. Signaturefd LLC now owns 1,211 shares of the company’s stock valued at $28,000 after buying an additional 1,005 shares in the last quarter. Quadrant Capital Group LLC lifted its stake in shares of Option Care Health by 172.8% in the 4th quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company’s stock valued at $40,000 after purchasing an additional 1,099 shares during the last quarter. Public Employees Retirement System of Ohio lifted its position in Option Care Health by 21.6% in the fourth quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company’s stock worth $43,000 after buying an additional 332 shares during the last quarter. Finally, Johnson Financial Group Inc. bought a new stake in shares of Option Care Health in the 4th quarter worth about $47,000. Institutional investors own 98.05% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on OPCH shares. Barrington Research restated an “outperform” rating and set a $38.00 price objective on shares of Option Care Health in a report on Thursday, July 10th. UBS Group raised shares of Option Care Health from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $38.00 to $40.00 in a report on Wednesday, April 30th. Finally, JMP Securities reiterated a “market outperform” rating and issued a $36.00 target price on shares of Option Care Health in a report on Wednesday, June 18th. One research analyst has rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $35.50.

Option Care Health Price Performance

Shares of OPCH opened at $29.48 on Friday. The firm has a market capitalization of $4.83 billion, a PE ratio of 23.77, a price-to-earnings-growth ratio of 1.81 and a beta of 0.73. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.54 and a quick ratio of 1.02. The company’s fifty day moving average price is $31.58 and its 200-day moving average price is $31.61. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $35.53.

Option Care Health (NASDAQ:OPCH) last posted its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.36 by $0.04. The company had revenue of $1.33 billion during the quarter, compared to analyst estimates of $1.26 billion. Option Care Health had a net margin of 4.12% and a return on equity of 16.90%. Option Care Health’s revenue for the quarter was up 16.3% compared to the same quarter last year. During the same period last year, the firm posted $0.26 EPS. On average, equities research analysts predict that Option Care Health, Inc. will post 1.22 EPS for the current year.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.